Skip to main content
VulnerabilityPublished

CVE-2026-32866: OPEXUS eCASE · Cross-site Scripting

Affects OPEXUS eCASESource CVE Database V5

0
Compare

Not known to be exploited · CVSS 5.1 Medium.

Data as of 31 Oct 2026, 20:20 UTC

CVSS 4.0 base score
5.1Medium
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.1% chance of exploitation in 30 days – higher than 3% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 19 Mar 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponized: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 31 Oct 2026.

What to do

Affected software

ProductAffectedFixed in
OPEXUSeCASEAffected
  • <10.1.0.0
Fixed in–

AI-suggested

To mitigate CVE-2026-32866, organizations should implement the following specific measures: 1) Apply vendor patches promptly once released for OPEXUS eCASE 10.2.0.0 or later versions that address this XSS vulnerability. 2) In the interim, enforce strict input validation on user profile fields, especially first and last names, to reject or sanitize potentially malicious characters or scripts. 3) Implement robust output encoding/escaping when rendering user-generated content to prevent script execution in browsers. 4) Employ Content Security Policy (CSP) headers to restrict the execution of unauthorized scripts and reduce the impact of XSS attacks. 5) Limit user permissions to reduce the number of authenticated users who can modify profile data. 6) Monitor application logs and user activity for suspicious behavior indicative of XSS exploitation attempts. 7) Educate users about phishing and social engineering risks that could facilitate exploitation. 8) Consider web application firewalls (WAFs) with XSS detection rules as an additional layer of defense. These targeted actions go beyond generic advice by focusing on both immediate containment and long-term remediation tailored to the vulnerability’s characteristics.

Description

CVE-2026-32866 is a medium severity cross-site scripting (XSS) vulnerability in OPEXUS eCASE versions prior to 10.2.0.0. It arises from improper sanitization of user profile fields, specifically the first and last name, allowing an authenticated attacker to inject malicious scripts. These scripts execute when the victim's full name is rendered, enabling session hijacking or other script-based attacks. Exploitation requires authentication and some user interaction, limiting but not eliminating risk. No known exploits are currently reported in the wild. The vulnerability impacts confidentiality, integrity, and availability to a limited extent due to the scope and conditions of exploitation. Organizations using OPEXUS eCASE should prioritize patching once available and implement input validation and output encoding as interim mitigations.

References

Community reviews

Loading reviews…